Group 4C: Lobular Breast Cancer; Predictive Biomarkers



Thursday, Dec 15
10:00 am – 11:30 am Eastern Time (US/New York)



Poster #P3-05-40

Association of body mass index with clinicopathological features and survival in patients with primary ER+/HER2- invasive lobular breast cancer

Poster author Karen Van Baelen, M.D. will attend this session

Poster #P3-05-04:

Absence of lobular carcinoma in situ, a poor prognostic marker in invasive lobular carcinoma

Mentor: Laurie Hutcheson, M.S.

Laurie Hutcheson is an ILC patient advocate and Executive Director of the Lobular Breast Cancer Alliance (LBCA). She received her master’s degree from the Harvard TH Chan School of Public Health and has been a leader in health care program development and management for over 40 years. Her experience includes executive roles in Massachusetts health and human services agencies, in behavioral health provider organizations and managing her own consulting business. Laurie joined LBCA as a volunteer following her diagnosis and treatment for invasive lobular carcinoma (ILC) in 2018. In May 2020, in lieu of retirement, she took over as LBCA’s executive director. Laurie is committed to working collaboratively with patient advocates, scientists, and clinicians in the U.S. and globally to raise awareness about ILC and to promote vitally needed ILC research.

Laurie is a Project Lead graduate. She is also an active research advocate in the Dana Farber/Harvard Cancer Center Breast Cancer Advocate group, and Komen Advocates in Science, and is on the board of the National Breast Cancer Coalition. She is a peer counselor with After Breast Cancer Diagnosis, and a member of the Metastatic Breast Cancer Alliance, and of the European Lobular Breast Cancer Consortium. She has also served as a GRASP mentor for the ILC-focused sessions.

Twitter: @lobularBCA

Scientist: Matteo Lambertini, M.D., Ph.D..

Matteo Lambertini is associate professor and consultant in medical oncology at the University of Genova – IRCCS Ospedale Policlinico San Martino in Genova (Italy). He is mainly focused in the care of breast cancer patients and is deeply involved in breast cancer research.

Above all, he has a particular expertise in the management of breast cancer in young women, with a specific attention to the fertility and pregnancy-related issues that they have to face after diagnosis.

Thanks to the support of the European Society for Medical Oncology (ESMO), in 2018 he completed his PhD at the Universite Libre de Bruxelles (U.L.B.) in Brussels (Belgium) with a project entitled “Unmet Fertility and Pregnancy-related Issues in Young Breast Cancer Patients”. With this work, he has contributed to improve our understanding of many controversial aspects related to the management of breast cancer in young women specifically focusing on fertility preservation and the possibility to have a pregnancy following treatment completion, with the ultimate goal to further improve the care and quality of life of these young women.

Twitter: @matteolambe